S65487

DB17556InvestigationalSmall molecule

S65487 a potent and selective BCL-2 inhibitor, and a prodrug of S55746.

Mechanism: Pharmacologically active on Apoptosis regulator Bcl-2
Curator reviewed
Also known as: VOB560

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with S65487, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.